ABSTRACT
Introduction Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are the global public health challenge. Family members of the HBV and HCV infected patients have a higher risk of exposure to many blood-borne diseases including Hepatitis B, and Hepatitis C viral infections as well. So the objectives of the present study was to evaluate seropositivity of HBV and HCV among family members of. chronic viral hepatitis patients.
Methods This study was conducted 80 family members of 50 patients with chronic HBV and HCV infection. After ethical clearance and written consent, 1st degree family members of those chronically infected hepatitis patients were explained about the objectives of the study and a standard questionnaire were introduced and recorded. Venous blood samples was taken from every participant with universal precautions and was tested by Enzyme Linked Immunosorbent assay (ELISA) for Hepatitis B surface antigen, anti HCV. Data analysis was done later by SPSS.
Results Eighty family members of 50 HBV and HCV positive cases where screened where HBV infection(45;90%) was more then HCV infection(5;90%). Male were 45(56.3%) and female were 35 (43.8%) male to male ratio 1.28:1. Total 23 (28.8%) subjects were vaccinated against HBV. One subject had history of blood transfusion and dental procedure each, extramarital sex activity was found in 2 (2.5%), and sleeping in the same room was found in 31(38.6%) subjects. History analysis revealed, 3(3.8%) were positive for HBV, 29 (36.3%) were found negative and 48(60%) were unaware of their status; again 77 (96.3%) are unaware of their anti HCV status. HBsAg and Anti HCV screening status of the relatives revealed HBsAg and anti HCV was found positive in 4 (5%) and 1 (1.3%) cases respectively.
Conclusion Relatives of the HBV and HCV infected patients are also at risk. So they should take proper preventive measures and should be vaccinated.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
None
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
ERB clearance was taken from ERB CMOSHMC
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available